Interwoven is partnering with TKDG and CHF Solutions, Inc. to create a wearable solution to aid patients while undergoing Aquapheresis therapy. For patients suffering from Congestive Heart Failure (CHF), fluid overload is a dangerous condition. If your heart is weakened by heart failure, your kidneys may not get enough blood to work as well as they should. As a result, your body retains salt and water in a misguided attempt to boost your blood volume. Aquapheresis therapy uses ultrafiltration to remove the excess fluid.
Wearable Health – Medical Design
What we did
- Design Research
- Concept Development
- Ideation and sketches
- Form Exploration
- Prototyping
- Medical Testing
Clients / Collaborators
Sketch Prototypes and Key Insights
Each prototype was built to address key insights from research phase. All sketch prototypes represent the core idea behind a product's function. We developed a color coding system that illustrates the primary and secondary function of each product concept.
Effective treatment for fluid overload
Aquapheresis is a medical therapy designed to remove excess salt and water from the body safely, predictably, and effectively from patients suffering from fluid overload for whom diuretics have failed.
Aquapheresis therapy, delivered by the Aquadex FlexFlow® System, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload.
Interwoven Partners with Tanaka Kapec
Rebeccah Pailes-Friedman, an expert in wearable technology and Jeffrey Kapec founder of Tanaka Kapec Design Group, have combined forces to form a a world class and award winning industrial design team that represents over 70 years of innovative product design experience in both wearable products and medical instruments. Together they are working with CHF Solutions, a global leader predicting, measuring, and optimizing fluid balance with their Aquadex FlexFlow® System and patented ultrafiltration Blood Circuit.
